Two-steps control of cellular prion physiology by the extracellular regulated kinase-1 (ERK1)

Prion

Volumn 6, Issue 1, 2012, Pages 23-25

  Checler, Frédéric ^a  

^a INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

ADAM proteases; AP 1; Cellular prion (PrP C); Extracellular regulated kinase 1 (ERK1); N1 fragment; p53; Processing; secretase; Protein kinase C (PKC) isoforms; Transcription

Indexed keywords

ALPHA SECRETASE; AMYLOID PRECURSOR PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; PRION PROTEIN; PROTEIN KINASE C; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

COMPARATIVE STUDY; CONTROLLED STUDY; HUMAN; NOTE; PATHOPHYSIOLOGY; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION;

ADAM PROTEINS; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 3; MODELS, BIOLOGICAL; PRIONS; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84857230723     PISSN: 19336896     EISSN: 1933690X     Source Type: Journal    
DOI: 10.4161/pri.6.1.18004     Document Type: Note

References (25)

1. Prusiner SB. Molecular biology and pathogenesis of prion diseases. Trends Biochem Sci 1996; 21:482-7; PMID:9009832; http://dx.doi.org/10.1016/S0968- 0004(96)10063-3.
2. Prusiner SB. Prions. Proc Natl Acad Sci USA 1998; 95:13363-83; PMID:9811807; http://dx.doi.org/10.1073/pnas.95.23.13363.
3. Tuite MF, Serio TR. The prion hypothesis: from biological anomaly to basic regulatory mechanism. Nat Rev Mol Cell Biol 2010; 11:823-33; PMID:21081963; http://dx.doi.org/10.1038/nrm3007.
4. Aguzzi A, O'Connor T. Protein aggregation diseases: pathogenicity and therapeutic perspectives. Nat Rev Drug Discov 2010; 9:237-48; PMID:20190788; http://dx.doi.org/10.1038/nrd3050.
5. Linden R, Martins VR, Prado MA, Cammarota M, Izquierdo I, Brentani RR. Physiology of the prion protein. Physiol Rev 2008; 88:673-728; PMID:18391177; http://dx.doi.org/10.1152/physrev.00007.2007.
6. Martins VR, Beraldo FH, Hajj GN, Lopes MH, Lee KS, Prado MM, et al. Prion Protein: Orchestrating Neurotrophic Activities. Curr Issues Mol Biol 2010; 12:63-86; PMID:19767651.
7. Paitel E, Fahraeus R, Checler F. Cellular prion protein sensitizes neurons to apoptotic stimuli through Mdm2-regulated and p53-dependent caspase 3-like activation. J Biol Chem 2003; 278:10061-6; PMID:12529324; http://dx.doi.org/10.1074/jbc.M211580200.
8. Paitel E, Sunyach C, Alves da Costa C, Bourdon JC, Vincent B, Checler F. Primary cultured neurons devoid of cellular prion display lower responsiveness to staurosporine through the control of p53 at both transcriptional and post-transcriptional levels. J Biol Chem 2004; 279:612-8; PMID:14570892; http://dx.doi.org/10.1074/jbc.M310453200.
9. Sunyach C, Checler F. Combined pharmacological, mutational and cell biology approaches indicate that p53-dependent caspase 3 activation triggered by cellular prion is dependent on its endocytosis. J Neurochem 2005; 92:1399-407; PMID:15748158; http://dx.doi.org/10.1111/j.1471-4159.2004.02989.x.
10. Guillot-Sestier MV, Sunyach C, Druon C, Scarzello S, Checler F. The alpha-secretase-derived N-terminal product of cellular prion, N1, displays neuroprotective function in vitro and in vivo. J Biol Chem 2009; 284:35973-86; PMID:19850936; http://dx.doi.org/10.1074/jbc.M109.051086.
11. Sunyach C, Cisse MA, da Costa CA, Vincent B, Checler F. The C-terminal products of cellular prion protein processing, C1 and C2, exert distinct influence on p53-dependent staurosporine-induced caspase-3 activation. J Biol Chem 2007; 282:1956-63; PMID:17121821; http://dx.doi.org/10.1074/jbc.M609663200.
12. Chen SG, Teplow DB, Parchi P, Teller JK, Gambetti P, Autilio-Gambetti L. Truncated forms of the human prion protein in normal brain and in prion disease. J Biol Chem 1995; 270:19173-80; PMID:7642585; http://dx.doi.org/10.1074/jbc. 270.32.19173.
13. Ancolio K, Marambaud P, Dauch P, Checler F. α-secretase-derived product of β-amyloid precursor protein is decreased by presenilin 1 mutations linked to familial Alzheimer's disease. J Neurochem 1997; 69:2494-9; PMID:9375682; http://dx.doi.org/10.1046/j.1471-4159.1997.69062494.x.
14. Lopez-Perez E, Zhang Y, Frank SJ, Creemers J, Seidah N, Checler F. Constitutive alpha-secretase cleavage of the beta-amyloid precursor protein in the furin-deficient LoVo cell line: involvement of the pro-hormone convertase 7 and the disintegrin metalloprotease ADAM10. J Neurochem 2001; 76:1532-9; PMID:11238737; http://dx.doi.org/10.1046/j.1471-4159.2001.00180.x.
15. Marambaud P, Lopez-Perez E, Wilk S, Checler F. Constitutive and protein kinase C-regulated secretory cleavage of Alzheimer's β amyloid precursor protein: different control of early and late events by the proteasome. J Neurochem 1997; 69:2500-5; PMID:9375683; http://dx.doi.org/10.1046/j.1471-4159. 1997.69062500.x.
16. Lammich S, Kojro E, Postina R, Gilbert S, Pfeiffer R, Jasionowski M, et al. Constitutive and regulated α-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. Proc Natl Acad Sci USA 1999; 96:3922-7; PMID:10097139; http://dx.doi.org/10.1073/pnas.96.7.3922.
17. Buxbaum JD, Liu KN, Luo Y, Slack JL, Stocking KL, Peschon JJ, et al. Evidence that tumor necrosis factor α converting enzyme is involved in regulated α-secretase cleavage of the Alzheimer amyloid protein precursor. J Biol Chem 1998; 273:27765-7; PMID:9774383; http://dx.doi.org/10.1074/jbc.273. 43.27765.
18. Vincent B, Checler F. α-secretase in Alzheimer's disease and beyond: mechanistic, regulation and function. Curr Alzheimer Res 2011; In press; PMID:21605031.
19. Vincent B, Paitel E, Frobert Y, Lehmann S, Grassi J, Checler F. Phorbol ester-regulated cleavage of normal prion protein in HEK293 human cells and murine neurons. J Biol Chem 2000; 275:35612-6; PMID:10952979; http://dx.doi.org/10.1074/jbc.M004628200.
20. Vincent B, Paitel E, Saftig P, Frobert Y, Hartmann D, De Strooper B, et al. The disintegrins ADAM10 and TACE contribute to the constitutive and phorbol ester-regulated normal cleavage of the cellular prion protein. J Biol Chem 2001; 276:37743-6; PMID:11477090.
21. Cissé M, Duplan E, Guillot-Sestier MV, Rumigny J, Bauer C, Pages G, et al. The extracellular regulated kinase-1 (ERK1) controls regulated {alpha}-secretase-mediated processing, promoter transactivation and mRNA levels of the cellular prion protein. J Biol Chem 2011; 286:29192-206; PMID:21586567; http://dx.doi.org/10.1074/jbc.M110.208249.
22. Boutros T, Chevet E, Metrakos P. Mitogen-activated protein (MAP) kinase/MAP kinase phosphatase regulation: roles in cell growth, death and cancer. Pharmacol Rev 2008; 60:261-310; PMID:18922965; http://dx.doi.org/10. 1124/pr.107.00106.
23. Checler F, Vincent B. Alzheimer's and prion diseases: distinct pathologies, common proteolytic denominators. Trends Neurosci 2002; 25:616-20; PMID:12446128; http://dx.doi.org/10.1016/S0166-2236(02)02263-4.
24. Alfa Cissé M, Louis K, Braun U, Mari B, Leitges M, Slack BE, et al. Isoform-specific contribution of protein kinase C to prion processing. Mol Cell Neurosci 2008; 39:400-10; PMID:18722532; http://dx.doi.org/10.1016/j.mcn. 2008.07.013.
25. Cisse M, Braun U, Leitges M, Fisher A, Pages G, Checler F, et al. ERK1-independent alpha-secretase cut of beta-amyloid precursor protein via M1 muscarinic receptors and PKCalpha/epsilon. Mol Cell Neurosci 2011; 47:223-32; PMID:21570469; http://dx.doi.org/10.1016/j.mcn.2011.04.008.